Pfizer's Covid vaccine and treatment drive second-quarter earnings beat

The pharmaceutical company booked net income of $9.9 billion, a 78% increase over the same period during 2021.
Data & News supplied by
Stock quotes supplied by Barchart
Quotes delayed at least 20 minutes.
By accessing this page, you agree to the following
Privacy Policy and Terms and Conditions.